Loading clinical trials...
Loading clinical trials...
Pilot, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety Clinical Activity of CCX282-B in Patients With Moderate to Severe Crohn's Disease
Conditions
Interventions
CCX282-B
Locations
14
United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Rocky Mountain Clincal Research
Golden, Colorado, United States
Arapahoe Gastroenterology
Littleton, Colorado, United States
Atlanta Gastroenterology Associates
Atlanta, Georgia, United States
University of Chicago
Chicago, Illinois, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
Start Date
August 1, 2004
Completion Date
December 1, 2005
Last Updated
March 6, 2025
NCT05421455
NCT07245394
NCT07089420
NCT05698745
NCT06896305
NCT06257706
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions